Launch 22 Sept 2009 · costs from the KID as of 2 Sept 2026 · 59 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
By subscribing to Amundi Stoxx Europe 50 UCITS ETF (the "Fund"), you are investing in a passive management UCITS whose objective is to replicate, as accurately as possible, the performance of the STOXX Europe 50 index (the "Index"), regardless of its performance, positive or negative. The maximum tracking error objective between the growth of the net asset value of the Fund and that of the Index is indicated in the Fund's prospectus. The Index, net dividends reinvested (dividends net of tax paid by the shares in the Index are included in the Index…
Performance since series start (in euro) — base 100
10 Jul 2017 → 8 Sept 2026 · dividends reinvested where declared by the issuer
High 230 (7 Aug 2026) · low 84 (16 Mar 2020) · last 225. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/FR0010790980 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.